Short answer

EU MDR certified SaMD can be included in the Australian Register of Therapeutic Goods (ARTG) using the EU Notified Body certificate as comparable overseas regulator evidence (TGA guidance version 2.1, May 2026). An Australian sponsor submits it as manufacturer evidence, which must match the device, design, intended purpose and user and be accepted before the ARTG application. Determine the Australian class under Australia’s own rules rather than copying your Rule 11 class. Class IIa devices are not subject to mandatory application audit, although the TGA can select any application for a non-mandatory audit, and its guidance sets no standard processing time.

The key fact most SaMD companies miss about TGA and EU MDR

Australia's Therapeutic Goods Administration (TGA) regulates medical devices under the Therapeutic Goods Act 1989 and the Therapeutic Goods (Medical Devices) Regulations 2002, with its own classification rules and essential principles. What matters most for companies with EU MDR certification is that the TGA recognises and relies on marketing approvals from comparable overseas regulators. Its guidance on using this evidence lists, among others, EU notified body certificates under the EU MDR, UK approved body certificates, FDA 510(k) and PMA decisions, Health Canada licences, Japanese approvals, Singapore HSA registrations, and MDSAP certificates and audit reports.

This does not mean EU MDR certification "exempts" you from TGA scrutiny. It means your EU certificate can be used as the manufacturer evidence supporting your ARTG application, instead of a separate TGA conformity assessment — provided it is for the same device, with the same design, intended purpose and user.

Which TGA document to read: the TGA guidance "Use of market authorisation evidence from comparable overseas regulators for medical devices (including IVDs)", version 2.1 (May 2026), sets out which overseas certificates are accepted for which device class (its Table 2). For example, for a Class IIa device, an EU MDR certificate under Annex IX Chapter I (QMS), or under Annex XI Part A or Part B, can serve as manufacturer evidence. Singapore HSA registrations are on the list too — relevant if you are also following our Singapore HSA registration guide.

TGA SaMD classification — check it, do not assume it

The TGA uses Class I, IIa, IIb and III for general medical devices — the same labels as the EU MDR — but the classification rules are Australia's own. The Australian class of your SaMD must be determined under the Australian regulations; do not assume it equals your EU MDR class under Rule 11 (see our EU MDR Rule 11 guide for the EU side). The class matters because the TGA's table of acceptable overseas evidence is organised by class: the EU certificate you rely on has to fit the line for the Australian class of your device.

Before you plan the application, check the TGA's current guidance on software-based medical devices to confirm that your software is in scope for ARTG inclusion and how it is classified in Australia.

The ARTG inclusion process for EU MDR certified SaMD

Getting your SaMD included in the ARTG involves the following steps:

  1. Work through an Australian sponsor: applications for ARTG inclusion are made by the sponsor, which holds the ARTG entry and carries the Australian post-market obligations, such as adverse event reporting, recalls and correspondence with the TGA. Overseas manufacturers typically use a distributor, an Australian subsidiary or a dedicated sponsorship service.
  2. Submit your manufacturer evidence first: under the TGA guidance, the manufacturer evidence — for example your EU MDR certificate — must be submitted, assessed and accepted before the ARTG application is made. It must match the device or device group, design, intended purpose and user of the Australian application.
  3. Prepare the ARTG application: the application must include the required device information and the declaration of conformity under the Australian requirements. All accompanying information must be in English or come with a certified translation. Have your clinical evidence available to support the device's intended purpose and claims.
  4. Preliminary assessment and decision: an application that does not pass preliminary assessment is refused, so completeness matters. The TGA may request further information, and it may select the application for audit (see below).

What TGA requires beyond EU MDR documentation

Your EU MDR technical file covers the core of what TGA needs, but several Australia-specific elements are required:

  • Australian declaration of conformity: made by the manufacturer in accordance with the Australian requirements, referencing the Australian legislation rather than (or in addition to) your EU MDR declaration.
  • Australian labelling: check your labels and instructions for use against the Australian essential principles before supply; EU labelling is a starting point, not automatically compliant.
  • Post-market obligations under Australian law: adverse event reporting to the TGA, recalls and maintenance of the ARTG entry are governed by Australian law, not the EU MDR. Your QMS needs procedures that cover them, coordinated with your sponsor.
  • Cybersecurity: expect the same depth of questions as in the EU; documentation built to MDCG 2019-16 is a good basis, but check it against the Australian essential principles.

Application audits — mandatory and non-mandatory

Some ARTG applications must be selected for an application audit under regulation 5.3 of the Medical Devices Regulations. These mandatory audits concern certain higher-risk devices (for example Class III devices and certain IVDs) — Class IIa devices are not subject to mandatory application audit. Separately, the TGA may select any other application for a non-mandatory audit, for example where there are known performance or use issues with a device; the guidance specifically notes that Class IIb applications may be selected. Audits can be conducted at Level 1 or Level 2, and sponsors can ask for an audit to be abridged from Level 2 to Level 1 and for reduced fees where justified.

To reduce the risk of questions: make sure your EU MDR certificate covers exactly the device and intended purpose described in your Australian application, that your clinical evidence is current and supports the Australian classification, and that your QMS covers Australian post-market obligations.

Important classification check: if your SaMD is Class IIa under EU MDR but a higher class in Australia, check whether your EU certificate still fits the TGA's evidence table for the Australian class. If it does not, you may need other evidence or a TGA conformity assessment. Verify the Australian classification before submission — this is a common and avoidable source of delays.

MDSAP — the optional audit efficiency multiplier

Australia participates in the Medical Device Single Audit Program (MDSAP), together with the USA, Canada, Japan and Brazil, and the TGA accepts MDSAP certificates and audit reports as manufacturer evidence. For SaMD companies targeting several of these markets, one MDSAP audit by a recognised auditing organisation can replace several separate QMS audits. If you do not yet hold the EU MDR certificate this route builds on, our EU MDR consulting covers the path to it.

Official sources & references